Contact
Privacy Policy

Copyright © DEEPNOID Inc. All rights reserved.

All news

November 28, 2025
Medical AI

DEEPNOID’s M4CXR Becomes the First Generative AI-Based Medical Device in Korea to Receive MFDS Innovative Medical Device Designation

DEEPNOID’s M4CXR Becomes the First Generative AI-Based Medical Device in Korea to Receive MFDS Innovative Medical Device Designation
November 20, 2025
Research

DEEPNOID Has Five Abstracts Accepted at RSNA 2025, Demonstrating the Clinical Potential of Its Medical AI Models

DEEPNOID Has Five Abstracts Accepted at RSNA 2025, Demonstrating the Clinical Potential of Its Medical AI Models
October 28, 2025
Research

DEEPNOID Takes First and Second Place at TopBrain Challenge, a Global Medical Imaging AI Competition, Demonstrating Its Cerebrovascular Segmentation Technology on CTA and MRA

DEEPNOID Takes First and Second Place at TopBrain Challenge, a Global Medical Imaging AI Competition, Demonstrating Its Cerebrovascular Segmentation Technology on CTA and MRA
October 22, 2025
Medical AI

DEEPNOID Partners with HealthHub on an AI Pilot Project in Indonesia, Integrating Its Generative AI-Based M4CXR and Conducting Clinical Validation

DEEPNOID Partners with HealthHub on an AI Pilot Project in Indonesia, Integrating Its Generative AI-Based M4CXR and Conducting Clinical Validation
October 14, 2025
Medical AI

DEEPNOID Partners with SG Healthcare to Enter Uzbekistan, Launching Its Push into the Global Medical AI Market Starting with Central Asia

DEEPNOID Partners with SG Healthcare to Enter Uzbekistan, Launching Its Push into the Global Medical AI Market Starting with Central Asia
September 29, 2025
Research

DEEPNOID Wins Awards at VLM3D Challenge, a Global Medical Imaging AI Competition, Demonstrating Generative AI Capabilities in CT Imaging

DEEPNOID Wins Awards at VLM3D Challenge, a Global Medical Imaging AI Competition, Demonstrating Generative AI Capabilities in CT Imaging
September 23, 2025
Research

DEEPNOID’s RadZero Paper Accepted at NeurIPS 2025, Achieving State-of-the-Art Performance on Eight Benchmarks for Zero-Shot Tasks

DEEPNOID’s RadZero Paper Accepted at NeurIPS 2025, Achieving State-of-the-Art Performance on Eight Benchmarks for Zero-Shot Tasks
July 31, 2025
Industry AI

DEEPNOID Selected as Lead R&D Institution for MOTIE’s KRW 11.6 Billion Medical-Specialized Hyperscale Generative AI Project

DEEPNOID Selected as Lead R&D Institution for MOTIE’s KRW 11.6 Billion Medical-Specialized Hyperscale Generative AI Project
July 25, 2025
Research

DEEPNOID Has Six Abstracts Accepted at ESNR 2025, Including Research on AI Diagnosis of Cerebrovascular Diseases

DEEPNOID Has Six Abstracts Accepted at ESNR 2025, Including Research on AI Diagnosis of Cerebrovascular Diseases
June 18, 2025
Research

DEEPNOID’s M4CXR Study Wins Best Oral Presentation at ESTI 2025, Demonstrating Clinical Potential at an International Congress

DEEPNOID’s M4CXR Study Wins Best Oral Presentation at ESTI 2025, Demonstrating Clinical Potential at an International Congress
May 15, 2025
Medical AI

DEEPNOID Signs MOU with KMI Korea Medical Institute for AI Monitoring Research on Health Screening Result Assessment

DEEPNOID Signs MOU with KMI Korea Medical Institute for AI Monitoring Research on Health Screening Result Assessment
February 28, 2025
Medical AI

DEEPNOID bets on Japan as AI testing ground before a push into US

DEEPNOID bets on Japan as AI testing ground before a push into US
November 1, 2024
Medical AI

DEEPNOID’s Cerebral Aneurysm AI Solution Becomes the First to Receive a Provisional Listing Fee under National Health Insurance, Enabling Non-Reimbursable Billing

DEEPNOID’s Cerebral Aneurysm AI Solution Becomes the First to Receive a Provisional Listing Fee under National Health Insurance, Enabling Non-Reimbursable Billing
October 21, 2024
Corporation

DEEPNOID Establishes Dubai Branch to Accelerate Entry into GCC Medical and Security Markets

DEEPNOID Establishes Dubai Branch to Accelerate Entry into GCC Medical and Security Markets
August 18, 2023
Medical AI

DEEPNOID’s DEEP:NEURO, Brain Image Detection and Diagnostic Assistance Software for Cerebral Aneurysms, Designated as an Innovative Medical Technology

DEEPNOID’s DEEP:NEURO, Brain Image Detection and Diagnostic Assistance Software for Cerebral Aneurysms, Designated as an Innovative Medical Technology